BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 8207231)

  • 1. Upstream NFIL-6-like site located within a DNase I hypersensitivity region mediates LPS-induced transcription of the murine interleukin-1 beta gene.
    Godambe SA; Chaplin DD; Takova T; Bellone CJ
    J Immunol; 1994 Jul; 153(1):143-52. PubMed ID: 8207231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NFIL-6 sequence near the transcriptional initiation site is necessary for the lipopolysaccharide induction of murine interleukin-1 beta.
    Godambe SA; Chaplin DD; Takova T; Bellone CJ
    DNA Cell Biol; 1994 Jun; 13(6):561-9. PubMed ID: 8024700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Ig germ-line gamma 1 promoter. Involvement of C/enhancer-binding protein transcription factors and their possible interaction with an NF-IL-4 site.
    Lundgren M; Larsson C; Femino A; Xu M; Stavnezer J; Severinson E
    J Immunol; 1994 Oct; 153(7):2983-95. PubMed ID: 8089482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-beta A-binding element, not an overlapping NF-IL-6-binding element, is required for maximal IL-1 beta gene expression.
    Buras JA; Monks BG; Fenton MJ
    J Immunol; 1994 May; 152(9):4444-54. PubMed ID: 8157962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA elements and protein factors involved in the transcription of the beta 2-adrenergic receptor gene in rat liver. The negative regulatory role of C/EBP alpha.
    Jiang L; Gao B; Kunos G
    Biochemistry; 1996 Oct; 35(40):13136-46. PubMed ID: 8855951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements.
    Li SP; Goldman ND
    Biochemistry; 1996 Jul; 35(28):9060-8. PubMed ID: 8703909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.
    van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of NF-kappaB p50/p65 heterodimer in activation of the human pro-interleukin-1beta gene at two subregions of the upstream enhancer element.
    Goto M; Katayama KI; Shirakawa F; Tanaka I
    Cytokine; 1999 Jan; 11(1):16-28. PubMed ID: 10080875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
    Jiang JG; Chen Q; Bell A; Zarnegar R
    Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
    Barber MC; Vallance AJ; Kennedy HT; Travers MT
    Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordination of transcription factors, NF-Y and C/EBP beta, in the regulation of the mdr1b promoter.
    Yu L; Wu Q; Yang CP; Horwitz SB
    Cell Growth Differ; 1995 Dec; 6(12):1505-12. PubMed ID: 9019155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes.
    Ochrietor JD; Harrison KA; Zahedi K; Mortensen RF
    Cytokine; 2000 Jul; 12(7):888-99. PubMed ID: 10880233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
    Kunsch C; Lang RK; Rosen CA; Shannon MF
    J Immunol; 1994 Jul; 153(1):153-64. PubMed ID: 8207232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions.
    Smith MF; Eidlen D; Brewer MT; Eisenberg SP; Arend WP; Gutierrez-Hartmann A
    J Immunol; 1992 Sep; 149(6):2000-7. PubMed ID: 1387669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of CCAAT/enhancer binding protein isoforms by serum and glucocorticoids in the rat intestinal epithelial crypt cell line IEC-6.
    Boudreau F; Blais S; Asselin C
    Exp Cell Res; 1996 Jan; 222(1):1-9. PubMed ID: 8549649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6.
    Ohmori Y; Smith MF; Hamilton TA
    J Immunol; 1996 Sep; 157(5):2058-65. PubMed ID: 8757327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.
    Ebb D; Tang DC; Drew L; Chin K; Berg PE; Rodgers GP
    Blood Cells Mol Dis; 1998 Sep; 24(3):356-69. PubMed ID: 10087993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the murine C5a receptor gene: NF-Y is required for basal and LPS induced expression in macrophages and endothelial cells.
    Hunt JR; Martin CB; Martin BK
    Mol Immunol; 2005 Jul; 42(11):1405-15. PubMed ID: 15950736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
    Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
    J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells.
    Harrison JR; Kelly PL; Pilbeam CC
    J Bone Miner Res; 2000 Jun; 15(6):1138-46. PubMed ID: 10841183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.